Glaxo profits up

GlaxoSmithKline, the world's second largest drug maker by revenues, posted an 11 percent rise in second quarter profit on Wednesday after strong pharmaceutical sales in emerging markets helped offset the impact of generic competition in the United States.

Glaxo profits up 11 percent on emerging markets

GlaxoSmithKline, the world's second largest drug maker by revenues, posted an 11 percent rise in second quarter profit on Wednesday after strong pharmaceutical sales in emerging markets helped offset the impact of generic competition in the United States.... Sponsored Topics: GlaxoSmithKline - United States - Pharmaceutical industry - Business - pharmaceutical

Alzheimer's Disease Conference (ICAD) Highlights Promise and Setbacks

RESEARCH TRIANGLE PARK, NC--(Marketwire - July 20, 2009) - As is often the case, recent news regarding potential treatments for Alzheimer's disease contains both promise and disappointment. The International Conference on Alzheimer's Disease (ICAD) draws attention to the leading science behind the fight against the disease. A major announcement preceded the conference, held in Vienna, Austria, ...